97TH GENERAL ASSEMBLY
State of Illinois
2011 and 2012
HB2978

 

Introduced 2/23/2011, by Rep. John E. Bradley

 

SYNOPSIS AS INTRODUCED:
 
225 ILCS 65/65-40  was 225 ILCS 65/15-20

    Amends the Nurse Practice Act. Provides that a collaborating physician or podiatrist may, but is not required to, delegate prescriptive authority to an advanced practice nurse as part of a written collaborative agreement of Schedule II (instead of III) through V controlled substances. Effective immediately.


LRB097 09161 CEL 49296 b

 

 

A BILL FOR

 

HB2978LRB097 09161 CEL 49296 b

1    AN ACT concerning regulation.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Nurse Practice Act is amended by changing
5Section 65-40 as follows:
 
6    (225 ILCS 65/65-40)   (was 225 ILCS 65/15-20)
7    (Section scheduled to be repealed on January 1, 2018)
8    Sec. 65-40. Prescriptive authority.
9    (a) A collaborating physician or podiatrist may, but is not
10required to, delegate prescriptive authority to an advanced
11practice nurse as part of a written collaborative agreement.
12This authority may, but is not required to, include
13prescription of, selection of, orders for, administration of,
14storage of, acceptance of samples of, and dispensing over the
15counter medications, legend drugs, medical gases, and
16controlled substances categorized as any Schedule II III
17through V controlled substances, as defined in Article II of
18the Illinois Controlled Substances Act, and other
19preparations, including, but not limited to, botanical and
20herbal remedies. The collaborating physician or podiatrist
21must have a valid current Illinois controlled substance license
22and federal registration to delegate authority to prescribe
23delegated controlled substances.

 

 

HB2978- 2 -LRB097 09161 CEL 49296 b

1    (b) To prescribe controlled substances under this Section,
2an advanced practice nurse must obtain a mid-level practitioner
3controlled substance license. Medication orders shall be
4reviewed periodically by the collaborating physician or
5podiatrist.
6    (c) The collaborating physician or podiatrist shall file
7with the Department notice of delegation of prescriptive
8authority and termination of such delegation, in accordance
9with rules of the Department. Upon receipt of this notice
10delegating authority to prescribe any Schedule III through V
11controlled substances, the licensed advanced practice nurse
12shall be eligible to register for a mid-level practitioner
13controlled substance license under Section 303.05 of the
14Illinois Controlled Substances Act.
15    (d) (Blank). In addition to the requirements of subsections
16(a), (b), and (c) of this Section, a collaborating physician
17may, but is not required to, delegate authority to an advanced
18practice nurse to prescribe any Schedule II controlled
19substances, if all of the following conditions apply:
20        (1) No more than 5 Schedule II controlled substances by
21    oral dosage may be delegated.
22        (2) Any delegation must be controlled substances that
23    the collaborating physician prescribes.
24        (3) Any prescription must be limited to no more than a
25    30-day oral dosage, with any continuation authorized only
26    after prior approval of the collaborating physician.

 

 

HB2978- 3 -LRB097 09161 CEL 49296 b

1        (4) The advanced practice nurse must discuss the
2    condition of any patients for whom a controlled substance
3    is prescribed monthly with the delegating physician.
4    (e) Nothing in this Act shall be construed to limit the
5delegation of tasks or duties by a physician to a licensed
6practical nurse, a registered professional nurse, or other
7persons.
8(Source: P.A. 95-639, eff. 10-5-07; 96-189, eff. 8-10-09.)
 
9    Section 99. Effective date. This Act takes effect upon
10becoming law.